CITADEL ADVISORS LLC

Holdings History for LENZ Therapeutics, Inc. - Common Stock, par value $0.00001 per share (LENZ)

Symbol: LENZ on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	-0%	$1,289,184	80,574	-318,856	-80%	$16.00	Q4 2025
31 Dec 2025	call	0%	+0%	$318,400	19,900	+5,500	+38%	$16.00	Q4 2025
31 Dec 2025	put	0%	+0%	$1,313,600	82,100	+57,200	+230%	$16.00	Q4 2025
30 Sep 2025		0.01%	+0.01%	$18,605,449	399,430	+390,393	+4320%	$46.58	Q3 2025
30 Sep 2025	call	0%	+0%	$670,752	14,400	+14,400	NEW	$46.58	Q3 2025
30 Sep 2025	put	0%	+0%	$1,159,842	24,900	+14,500	+139%	$46.58	Q3 2025
30 Jun 2025		0%	-0%	$264,874	9,037	-557	-5.8%	$29.31	Q2 2025
30 Jun 2025	put	0%	+0%	$304,824	10,400	+10,400	NEW	$29.31	Q2 2025
31 Mar 2025		0%	+0%	$246,662	9,594	+9,594	NEW	$25.71	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.